The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both companies. In fact, Amicus could potentially double its reach, going from 40 ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best NASDAQ stocks to buy in 2026. On December 22, H.C. Wainwright raised the firm’s price target on BioMarin to $60 from $55 with a Neutral ...
BETHLEHEM, Pa. -- A New York-based investment group that leases housing to students has acquired dozens of South Bethlehem properties near Lehigh University. Northampton County records show 46 ...
08/01/2024 Motion to extend the time to file a response from August 14, 2024 to October 14, 2024, submitted to The Clerk. 08/02/2024 Motion to extend the time to file a response is granted and the ...
06/30/2025 Petition GRANTED limited to the following question: Whether 29 U. S. C. §1391’s instruction to compute withdrawal liability “as of the end of the plan year” requires the plan to base the ...
The National Women’s Law Center is intervening in defense of transgender athletes in a lawsuit brought against the National Collegiate Athletics Association attempting to force the organization to ...
Thousands of school districts across the country operate with nondiscrimination policies inclusive of their transgender students, including the legal right for these students to access facilities ...
Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results